About ROMPAG

"ROMPAG" belongs to Anti Neoplastics therapy of Oncology Division and it is available in 2 forms : Rompag 25 Mg Tablets and Rompag 50 Mg Tablets.

(Read More)
Rompag is a thrombopoietin receptor agonist developed to boost platelet counts in patients suffering from chronic immune thrombocytopenia (ITP), aplastic anemia, and hepatitis C-related thrombocytopenia.